Healthcare IT News: Bumrungrad International Hospital, a private multiple-specialty medical centre founded 1980 in Bangkok, Thailand, announced the launch of FoundationOne CDx, the first broad companion diagnostic assay to be endorsed by the USFDA in 2017. FoundationOne CDx is a next generation sequencing-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumour type.
This new comprehensive genomic profiling includes an updated gene list and alterations in the most commonly mutated genes known to drive the growth of cancer. New tests detail genomic signatures which can better direct treatment decisions.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now